SD
Sohilkumar Dahyabhai Tandel
About Sohilkumar Dahyabhai Tandel
Data last updated:
Sohilkumar Dahyabhai Tandel is a Director at Esperer Onco Nutrition Private Limited (since 2024) and Director at Esperer Bio-Research Private Limited (since 2018). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹6.89 Cr; the largest is Esperer Onco Nutrition Private Limited at ₹5.32 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Esperer Onco Nutrition Private Limited U24299MH2019PTC322571 | Director | 08 Aug 2024 | 2019 | ₹5.32 Cr (FY 2025) | Active |
 Esperer Bio-Research Private Limited U24304MH2018PTC312841 | Director | 16 Aug 2018 | 2018 | ₹1.57 Cr (FY 2024) | Active |
Board colleagues of Sohilkumar Dahyabhai Tandel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Raktim Chattopadhyay | Esperer Onco Nutrition Private Limited | Ceo | |
| Raktim Chattopadhyay | 08201473 | Esperer Onco Nutrition Private Limited , Esperer Bio-Research Private Limited | Director |
| Riddhesh Neema | 10877795 | Esperer Onco Nutrition Private Limited | Director |
| Sudipta Chattopadhyay | 08721831 | Esperer Onco Nutrition Private Limited , Esperer Bio-Research Private Limited | Director |
| Shubhankar Karmakar | 07695018 | Esperer Bio-Research Private Limited | Director |
| Venkataktyayani Sushmitha Gorantla | 05184696 | Esperer Bio-Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sohilkumar Dahyabhai Tandel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sohilkumar Dahyabhai Tandel
Sohilkumar Dahyabhai Tandel currently holds 2 directorships: Esperer Onco Nutrition Private Limited (Director, since 08 Aug 2024, revenue ₹5.32 Cr (FY 2025)); Esperer Bio-Research Private Limited (Director, since 16 Aug 2018, revenue ₹1.57 Cr (FY 2024)).
Sohilkumar Dahyabhai Tandel was first appointed on 16 Aug 2018 as Director at Esperer Bio-Research Private Limited. The most recent appointment on record is 08 Aug 2024 at Esperer Onco Nutrition Private Limited.
The 2 current companies of Sohilkumar Dahyabhai Tandel that report revenue have a combined latest revenue of ₹6.89 Cr: Esperer Onco Nutrition Private Limited ₹5.32 Cr (FY 2025); Esperer Bio-Research Private Limited ₹1.57 Cr (FY 2024).
The current boards of Sohilkumar Dahyabhai Tandel's companies include Raktim Chattopadhyay (Esperer Onco Nutrition Private Limited), Raktim Chattopadhyay (Esperer Onco Nutrition Private Limited), Riddhesh Neema (Esperer Onco Nutrition Private Limited), Sudipta Chattopadhyay (Esperer Onco Nutrition Private Limited), Shubhankar Karmakar (Esperer Bio-Research Private Limited), Venkataktyayani Sushmitha Gorantla (Esperer Bio-Research Private Limited).